Which treatment for hyperkalemia includes the use of calcium gluconate?

The use of calcium gluconate in the treatment of hyperkalemia is primarily indicated due to its protective effect on the cardiac myocardium. When hyperkalemia occurs, elevated potassium levels can lead to adverse cardiac effects, including arrhythmias and potential cardiac arrest. Calcium gluconate helps stabilize the cardiac membrane, reducing the risk of these complications.

In the case of medical management for high potassium levels, calcium gluconate is often administered alongside other treatments that address the underlying cause or help to decrease serum potassium. While treatments such as diuretics, dialysis, and insulin play roles in managing hyperkalemia, calcium gluconate specifically targets the cardiac effects of elevated potassium, making it an essential part of the emergency management protocol for patients with significant hyperkalemia, especially when there is evidence of cardiac involvement.

Thus, its inclusion in treatment is crucial for ensuring immediate cardiac safety while other treatments take effect to lower potassium levels in the body.